Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinhong decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by LongHua Hospital, Shanghai University of Traditional Chinese Medicine, specifically for the treatment of sepsis, severe sepsis, and septic shock. It typically comprises herbs such as *Rheum palmatum* (Dahuang), *Lonicera japonica* (Jinyinhua), and *Sargentodoxa cuneata* (Hongteng). The decoction is designed to improve the 28-day prognosis of septic patients by enhancing organ function, eliminating pathogens, and restoring internal homeostasis. Its mechanism of action involves the inhibition of systemic inflammatory responses, protection of the intestinal mucosal barrier, and modulation of the gut microbiota to prevent bacterial translocation and subsequent multi-organ dysfunction syndrome (MODS).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jinhong decoction.